EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 23 filers reported holding EVOKE PHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $278,000 | – | 184,812 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 245,000 | $1,727,000 | 0.80% |
| Knoll Capital Management, LLC | 53,839 | $380,000 | 0.11% |
| Financial Architects, Inc | 4,300 | $30,000 | 0.01% |
| C WorldWide Group Holding A/S | 45,100 | $318,000 | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 15,864 | $111,000 | 0.00% |
| BlackRock Investment Management, LLC | 489 | $3,000 | 0.00% |
| CITIGROUP INC | 6 | $0 | 0.00% |
| MORGAN STANLEY | 1,010 | $7,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 36,700 | $243,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 200 | $1,000 | 0.00% |